THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is 88339KAA0. A total of 20 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,381,000 | -2.7% | 1,500,000 | 0.0% | 0.04% | +11.1% |
Q1 2022 | $1,420,000 | -2.5% | 1,500,000 | 0.0% | 0.04% | +5.9% |
Q4 2021 | $1,456,000 | +4.7% | 1,500,000 | 0.0% | 0.03% | +17.2% |
Q3 2021 | $1,391,000 | -2.7% | 1,500,000 | 0.0% | 0.03% | +3.6% |
Q2 2021 | $1,429,000 | -6.4% | 1,500,000 | 0.0% | 0.03% | -15.2% |
Q1 2021 | $1,526,000 | +7.5% | 1,500,000 | 0.0% | 0.03% | +10.0% |
Q4 2020 | $1,420,000 | +7.6% | 1,500,000 | 0.0% | 0.03% | -9.1% |
Q3 2020 | $1,320,000 | -9.6% | 1,500,000 | 0.0% | 0.03% | -17.5% |
Q2 2020 | $1,460,000 | +0.8% | 1,500,000 | 0.0% | 0.04% | -33.3% |
Q1 2020 | $1,448,000 | -7.0% | 1,500,000 | 0.0% | 0.06% | +22.4% |
Q4 2019 | $1,557,000 | +13.2% | 1,500,000 | 0.0% | 0.05% | -10.9% |
Q3 2019 | $1,376,000 | +6.7% | 1,500,000 | 0.0% | 0.06% | +17.0% |
Q2 2019 | $1,290,000 | -11.5% | 1,500,000 | 0.0% | 0.05% | -16.1% |
Q1 2019 | $1,457,000 | -5.8% | 1,500,000 | 0.0% | 0.06% | -23.3% |
Q4 2018 | $1,547,000 | -12.6% | 1,500,000 | 0.0% | 0.07% | +14.1% |
Q3 2018 | $1,770,000 | +18.7% | 1,500,000 | 0.0% | 0.06% | +12.3% |
Q2 2018 | $1,491,000 | -1.6% | 1,500,000 | 0.0% | 0.06% | -12.3% |
Q1 2018 | $1,515,000 | -7.9% | 1,500,000 | 0.0% | 0.06% | -13.3% |
Q4 2017 | $1,645,000 | -10.8% | 1,500,000 | 0.0% | 0.08% | -11.8% |
Q3 2017 | $1,844,000 | -9.3% | 1,500,000 | 0.0% | 0.08% | -17.5% |
Q2 2017 | $2,032,000 | +7.0% | 1,500,000 | 0.0% | 0.10% | -6.4% |
Q1 2017 | $1,899,000 | +10.9% | 1,500,000 | 0.0% | 0.11% | -4.3% |
Q4 2016 | $1,713,000 | – | 1,500,000 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LINDEN ADVISORS LP | 71,957,000 | $88,374,000 | 3.14% |
Context Capital Management, LLC | 3,500,000 | $4,288,000 | 2.87% |
Mohican Financial Management, LLC | 1,000,000 | $1,250,000 | 2.40% |
Verition Fund Management LLC | 8,000,000 | $9,835,000 | 0.79% |
ZAZOVE ASSOCIATES LLC | 8,170,000 | $10,024,000 | 0.51% |
Baupost Group | 30,000,000 | $37,125,000 | 0.46% |
WOLVERINE ASSET MANAGEMENT LLC | 24,020,000 | $29,431,000 | 0.33% |
SSI INVESTMENT MANAGEMENT LLC | 3,007,000 | $3,683,000 | 0.31% |
CSS LLC/IL | 2,900,000 | $3,556,000 | 0.17% |
Rock Springs Capital Management LP | 1,500,000 | $1,844,000 | 0.08% |